𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme

✍ Scribed by Johannes E. A. Wolff; Gabriele Mölenkamp; Silke Westphal; Thorsten Pietsch; Astrid Gnekow; Rolf-Dieter Kortmann; Joachim Kuehl

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
92 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retinal toxicity associated with cisplat
Retinal toxicity associated with cisplatin and etoposide in pediatric patients
✍ Hilliard, Lee M.; Berkow, Roger L.; Watterson, Jan; Ballard, Evan A.; Balzer, Ge 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Cisplatin is an effective chemotherapeutic agent used in the treatment of many pediatric solid tumors. Retinal toxicity is a side effect of the drug reported in adults, but is not well described in pediatric patients. We present the cases of two children treated with cisplatin and etoposide who expe

Chemotherapy with etoposide, vincristine
Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma
✍ Gorgun Akpek; Howard K. Koh; Steven Bogen; Carl O'Hara; Francine M. Foss 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL). ## METHODS. Fifteen patients were tre

Severe myelotoxicity of oral etoposide i
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia
✍ Sharon Shaklai; Osnat Bairey; Dorit Blickstein; Miron Prokocimer; Herzlia Hadar; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

## BACKGROUND. Promising results have been reported for patients with non-Hodgkin's lymphoma (NHL) receiving chronic oral etoposide. Due to the small number of patients reported, information regarding side effects is limited, and therefore warrants further evaluation. ## METHODS. Twenty eligible

Chemotherapy in patients with prostate s
Chemotherapy in patients with prostate specific antigen–only disease after primary therapy for prostate carcinoma : A Phase II trial of oral estramustine and oral etoposide
✍ Hidayatullah G. Munshi; Kenneth J. Pienta; David C. Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## BACKGROUND. A Phase II study was initiated to evaluate the effectiveness of an oral regimen of etoposide and estramustine in patients with early recurrent prostate carcinoma. ## METHODS. Patients with early recurrent prostate carcinoma as indicated by an increasing prostate specific antigen